Virginia Drug Discovery Consortium

The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:

To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.

To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.

To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.

CancerRX

EVENTS

VirginiaDrugDiscoveryRx: A Symposium on Academic-Industrial Partnerships in Drug Discovery

June 25-26, at the Founders Hall, George Mason University: A symposium themed “Building Drug Discovery Partnerships” featuring presentations by successful entrepreneurs who have translated basic research into biotech companies, and by other drug discovery researchers who have promising drug candidates in development. The meeting is hosted by the Virginia Drug Discovery Consortium and VirginiaBio.

Who should attend?

  • Virginia scientists with drug discovery related research
  • Investors looking for promising new drug start-up companies
  • Pharmaceutical and Biotech companies looking for new leads

NEWS

VirginiaCancerRx in the News!

John Lazo (VaDDC, Univ. of Virginia Pharmacology), David Kingston (VaDDC, Virginia Tech Chemistry) and Thomas Loughran (Director, Univ. of Virginia Cancer Center) were interviewed by Charlottesville’s CBS affiliate regarding Virginia Drug Discovery Consortium’s 2017...

read more

AFFILIATES

VCU
Virginia Tech
UVA
ODU
EVMS
GMU
Virginia Biosciences Health Research Corporation

Want to work with us?

If you are interested in supporting this initiative, please contact us.